Novartis
NVS
NVS
874 hedge funds and large institutions have $17.3B invested in Novartis in 2016 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 335 increasing their positions, 345 reducing their positions, and 103 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
13% less capital invested
Capital invested by funds: $20B → $17.3B (-$2.65B)
40% less first-time investments, than exits
New positions opened: 62 | Existing positions closed: 103
50% less funds holding in top 10
Funds holding in top 10: 42 → 21 (-21)
Holders
874
Holding in Top 10
21
Calls
$32.3M
Puts
$32.7M
Top Buyers
| 1 | +$159M | |
| 2 | +$66.3M | |
| 3 | +$65.2M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$63.7M |
| 5 |
CI
Cambiar Investors
Denver,
Colorado
|
+$56.9M |
Top Sellers
| 1 | -$77.5M | |
| 2 | -$57.8M | |
| 3 | -$45.2M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$41.9M |
| 5 |
State Street
Boston,
Massachusetts
|
-$23M |